Expression Table for this CRE
| CNhi10525_AGT | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep1 | 18.2 |
| CNhs14595 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 13.5 |
| CNhs14434 | COBL-a rinderpest infection, 48hr, biol_rep3 | 10.6 |
| CNhs14600 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 8.3 |
| CNhs14606 | Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3 | 7.7 |
| CNhi10939_ACC | Human primary dermal lymphatic vascular endothelial cells, biol_rep1 | 6.6 |
| CNhs14591 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 6.2 |
| CNhs12587 | Perineurial Cells, donor1 | 6.0 |
| CNhs14532 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 5.8 |
| CNhs14549 | globus pallidus, adult, donor10258 | 5.2 |
| CNhs14603 | Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 5.0 |
| CNhs14082 | globus pallidus, newborn, donor10223 | 4.6 |
| CNhs14609 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3 | 4.6 |
| CNhs14618 | putamen, adult, donor10258 | 3.9 |
| CNhs14551 | thalamus, adult, donor10258 | 3.9 |
| CNhs14536 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2 | 3.8 |
| CNhs14559 | Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction) | 3.7 |
| CNhs14577 | Myoblast differentiation to myotubes, day00, control donor3 | 3.6 |
| CNhs14244 | carcinoid cell line:NCI-H727 | 3.5 |
| CNhs14601 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 3.4 |
| CNhs12838 | merkel cell carcinoma cell line:MKL-1 | 3.3 |
| CNhs14425 | COBL-a rinderpest infection, 12hr, biol_rep1 | 3.3 |
| CNhs14592 | Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1 | 3.2 |
| CNhs12086 | Renal Glomerular Endothelial Cells, donor2 | 3.2 |
| CNhs12826 | H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1) | 3.2 |
| CNhs14534 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 3.2 |
| CNhs14582 | Myoblast differentiation to myotubes, day06, control donor3 | 3.1 |
| CNhs14588 | Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 3.1 |
| CNhs14538 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 3.1 |
| CNhs14540 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3 | 3.0 |
| CNhs14550 | locus coeruleus, adult, donor10258 | 3.0 |
| CNhs12056 | Skeletal Muscle Cells, donor5 | 3.0 |
| CNhs12564 | MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1 | 3.0 |
| CNhs14406 | 293SLAM rinderpest infection, 00hr, biol_rep1 | 3.0 |
| CNhs14537 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3 | 3.0 |
| CNhi10941_CAC | Human primary dermal lymphatic vascular endothelial cells, biol_rep2 | 3.0 |
| CNhs14576 | Myoblast differentiation to myotubes, day12, control donor2 | 2.9 |
| CNhs13161 | Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5) | 2.9 |
| CNhs13480 | immature langerhans cells, donor2 | 2.9 |
| CNhs14429 | COBL-a rinderpest infection, 24hr, biol_rep2 | 2.8 |
| CNhs14556 | acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction) | 2.8 |
| CNhs12740 | MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1 | 2.8 |
| CNhs13067 | mesothelioma cell line:Mero-41 | 2.7 |
| CNhs14561 | Fibroblast - skin, normal donor2 (cytoplasmic fraction) | 2.7 |
| CNhs14190 | Smooth muscle cells - airway, control, donor1 | 2.7 |
| CNhs14613 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 2.6 |
| CNhs14129 | Fibroblast - Gingival, donor6 (control) | 2.6 |
| CNhs13843 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 2.6 |
| CNhs12862 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 2.6 |
| CNhs14214 | hIPS, biol_rep1 | 2.5 |